GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Agenus Inc. (AGEN) [hlAlert]

Rating:
Mkt Outperform
AGEN
up 72.75 %

Agenus Inc. (AGEN) rated Mkt Outperform by JMP Securities

Posted on: Tuesday,  Apr 2, 2013  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Agenus Inc. (NASDAQ: AGEN) on 04/02/2013, when the stock price was $4.00.
Since then, Agenus Inc. has gained 72.75% as of 01/21/2016's recent price of $6.91.
If you would have followed this JMP Securities's recommendation on AGEN, you would have gained 72.75% of your investment in 1024 days.

Antigenics Inc. is engaged in the discovery and development of a family of novel immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight disease. The company is evaluating the lead immunotherapeutic, Oncophage, in six separate phase II or phase I/II clinical trials in four different cancers. The company is also developing immunotherapeutics to treat infectious diseases, such as genital herpes, and autoimmune disorders, such as diabetes and multiple sclerosis.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/2/2013 8:25 AM Buy
None
4.00
as of 12/13/2013
1 Week down  -5.42 %
1 Month down  -1.21 %
3 Months down  -12.23 %
1 YTD down  -39.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy